Cornerstone Wealth Group, LLC Bristol Myers Squibb CO Transaction History
Cornerstone Wealth Group, LLC
- $1.35 Billion
- Q2 2025
A detailed history of Cornerstone Wealth Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Wealth Group, LLC holds 13,130 shares of BMY stock, worth $615,271. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,130
Previous 13,305
1.32%
Holding current value
$615,271
Previous $811,000
25.15%
% of portfolio
0.04%
Previous 0.07%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,736Shares Held
1.59BCall Options Held
26MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...